HCV status knowledge and risk behaviours amongst intravenous drug users

被引:34
|
作者
Vidal-Trécan, G [1 ]
Coste, J [1 ]
Varescon-Pousson, I [1 ]
Christoforov, B [1 ]
Boissonnas, A [1 ]
机构
[1] Univ Paris 05, CHU Cochin Port Royal, Dept Sante Publ, Univ Praticien Hosp, Paris, France
关键词
hepatitis C; injecting behaviours; intravenous; sex behaviours; substance abuse;
D O I
10.1023/A:1007622831518
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The aim of this study was to identify relationships between injecting and sexual risk behaviours and hepatitis C virus (HCV) status knowledge in intravenous drug users (IDUs). It was a cross-sectional survey (March 1994-June 1995) in 10 drug abuse treatment or psychosocial centres in Paris, France. We used a structured questionnaire about sexual, injecting, HIV and HCV antibody testing practices and results during the previous 6months. Six hundred and twelve sexually active IDUs aged 18 or older who were current injecting drug users were interviewed. Of 592 respondent IDUs, 37% did not report consistent HCV testing and 34% reported being HCV-positive. HCV-positive IDUs were older than HCV-negatives and HCV-unknowns. HCV-unknowns and HCV-positives had a lower educational level than HCV-negatives. After adjusting for demographic characteristics and HIV status, the factors associated with being HCV-unknown were not using condoms (OR: 2.9; 95% CI: 1.9-4.6) as well as clean equipment (OR: 1.8; 95% CI: 1.2-3.0). Not using new equipment was negatively associated with being HCV-unknown (OR: 0.4; 95% CI: 0.2-0.6) and with being HCV-positive (OR: 0.5; 95% CI: 0.3-0.8). Our study suggests that particular sexual and injecting risk-behaviours are associated with not knowing HCV status. As HCV-unknown IDUs are likely to be at the risk of transmitting HCV or acquiring other infections. HCV testing should be encouraged and associated with sexual counselling. Special attention should be paid to disinfecting practices for HCV-positives and use of new injecting equipment should be recommended for HCV-negatives.
引用
收藏
页码:439 / 445
页数:7
相关论文
共 50 条
  • [21] INTRAVENOUS-DRUG-USERS AND AIDS - RISK BEHAVIORS
    BOOTH, R
    KOESTER, S
    BREWSTER, JT
    WEIBEL, WW
    FRITZ, RB
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 1991, 17 (03): : 337 - 353
  • [22] HIV risk behaviour in Irish intravenous drug users
    A. Dorman
    E. Keenan
    C. Schuttler
    J. Merry
    J. J. O’Connor
    Irish Journal of Medical Science, 1997, 166 : 235 - 238
  • [23] HIV risk behaviour in Irish intravenous drug users
    Dorman, A
    Keenan, E
    Schuttler, C
    Merry, J
    OConnor, JJ
    IRISH JOURNAL OF MEDICAL SCIENCE, 1997, 166 (04) : 235 - 238
  • [24] Intravenous drug users and broken needles - a hidden risk?
    Norfolk, GA
    Gray, SF
    ADDICTION, 2003, 98 (08) : 1163 - 1166
  • [25] Protective KIR-HLA interactions for HCV infection in intravenous drug users
    Zuniga, Joaquin
    Romero, Viviana
    Azocar, Jose
    Terreros, Daniel
    Ines Vargas-Rojas, Maria
    Torres-Garcia, Diana
    Jimenez-Alvarez, Luis
    Vargas-Alarcon, Gilberto
    Granados-Montiel, Julio
    Husain, Zaheed
    Chung, Raymond T.
    Alper, Chester A.
    Yunis, Edmond J.
    MOLECULAR IMMUNOLOGY, 2009, 46 (13) : 2723 - 2727
  • [26] High prevalence of HBV and HCV infection among intravenous drug users in Korea
    Yun, Haesun
    Kim, Daijin
    Kim, Soyeon
    Kang, Sujin
    Jeong, Seunghee
    Cheon, Yonghoon
    Joe, Keunho
    Gwon, Do-Hoon
    Cho, Sung-Nam
    Jee, Youngmee
    JOURNAL OF MEDICAL VIROLOGY, 2008, 80 (09) : 1570 - 1575
  • [27] Factors associated with liver fibrosis in intravenous drug users coinfected with HIV and HCV
    Carton, Jose A.
    Collazos, Julio
    de la Fuente, Belen
    Luisa Garcia-Alcalde, Maria
    Suarez-Zarracina, Tomas
    Rodriguez-Guardado, Azucena
    Asensi, Victor
    ANTIVIRAL THERAPY, 2011, 16 (01) : 27 - 35
  • [28] Predictors of progression to cirrhosis in intravenous drug users (IVDUs) with chronic HCV infection
    Minola, E
    Prati, D
    Maggiolo, F
    Fraquelli, M
    Colucci, A
    Milani, S
    Suter, F
    Conte, D
    JOURNAL OF HEPATOLOGY, 2003, 38 : 164 - 164
  • [29] Predominance of HCV type 2a in saliva from intravenous drug users
    Roy, KM
    Bagg, J
    McCarron, B
    Good, T
    Cameron, S
    Pithie, A
    JOURNAL OF MEDICAL VIROLOGY, 1998, 54 (04) : 271 - 275
  • [30] Illegal drug users and risk factors for HIV and HCV infection
    Backmund, M.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2007, 50 (04) : 471 - 475